Working… Menu

A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02313077
Recruitment Status : Completed
First Posted : December 9, 2014
Last Update Posted : April 14, 2017
Information provided by (Responsible Party):
Crucell Holland BV